期刊文献+

直肠癌Miles术后会阴切口一期缝合引流方法的选择 被引量:7

原文传递
导出
摘要 目的:探讨直肠癌Miles术后会阴切口一期缝合不同引流方法对会阴部切口愈合的影响。方法:将近3年来收治的100例行直肠癌Miles术的患者随机分成对照组和观察组,每组50例。对照组在Miles术后会阴切口一期缝合仅行骶前负压管经腹部切口引流,会阴部未置引流;观察组则除在骶前间隙采用经腹部切口引流外,还在会阴部行单管负压引流。比较两组的引流量、引流时间、一期愈合率、创口感染率、残腔消失时间以及皮肤切口愈合时间。结果:观察组的引流量显著多于对照组,且引流时间显著短于对照组(均P<0.05);观察组的一期愈合率显著高于对照组,而创口感染率显著低于对照组(均P<0.05);观察组的残腔消失时间和皮肤切口愈合时间均显著短于对照组(均P<0.05)。结论:直肠癌Miles术后会阴切口一期缝合采用骶前间隙单管引流和会阴部单管负压引流的方法对会阴部切口愈合效果优于仅行髋前负压管经腹部切口引流的方法。
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2012年第10期1306-1307,共2页 China Journal of General Surgery
  • 相关文献

参考文献8

二级参考文献58

共引文献53

同被引文献56

  • 1郭天廓,王宇晗.直肠手术中骶前引流的出路探讨[J].中国医疗前沿(学术版),2008(4). 被引量:1
  • 2黄平,杨小冬,王锋,高一飞,沈杰,李德川,楼荣灿,陈贤贵.Miles术后会阴开放切口处理方法的改进[J].中国现代手术学杂志,2009,13(4):253-256. 被引量:7
  • 3贾振理,朱子宜,郭邓民,宋伟,赵玉军,陈永胜.促进Miles手术时会阴部切口愈合作用的探讨[J].浙江临床医学,2006,8(11):1193-1194. 被引量:3
  • 4Vincenzi B,Frezza AM,Schiavon G. Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox Ⅳ[J].{H}SUPPORTIVE CARE IN CANCER,2013,(05):1313-1319.
  • 5Georgiou PA,Tekkis PP,Constantinides VA. Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer[J].{H}EUROPEAN JOURNAL OF CANCER,2013,(01):72-81.
  • 6Mirakhorli M,Rahman SA,Abdullah S. Multidrug resistance protein 2 genetic polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4 chemotherapy[J].Mol Med Rep,2013,(02):613-617.
  • 7Ng SC,Lau JY,Chan FK. Increased risk of advanced neoplasms among asymptomatic siblings of patients with colorectal cancer[J].{H}GASTROENTEROLOGY,2013,(03):544-550.
  • 8Landry JC,Feng Y,Cohen SJ. Phase 2 study of preoperative radiation with concurrent capecitabine,oxaliplatin,and bevacizumab followed by surgery and postoperative 5-fluorouracil,leucovorin,oxaliplatin (FOLFOX),and bevacizumab in patients with locally advanced rectal cancer:ECOG 3204[J].{H}CANCER,2013,(08):1521-1527.
  • 9Vincenzi B,Zoccoli A,Schiavon G. Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients[J].{H}EUROPEAN JOURNAL OF CANCER,2013,(06):1501-1508.
  • 10Infante JR,Bendell JC,Goff LW. Safety,pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody,KRN330,in patients with advanced colorectal cancer[J].{H}EUROPEAN JOURNAL OF CANCER,2013,(06):1169-1175.

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部